New mpox vaccine shows promise in early trial
NCT ID NCT05988203
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 31 times
Summary
This study tested a new RNA-based vaccine (BNT166a) to prevent mpox (monkeypox). About 96 healthy adults received different doses to check safety and how well the vaccine triggers an immune response. The trial is complete, and results will help decide if the vaccine should move to larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MONKEYPOX are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Addenbrooke's Hospital - Cambridge University Hospitals NHS Foundation Trust
Cambridge, CB2 0QQ, United Kingdom
-
Alliance for Multispecialty Research, LLC
Kansas City, Missouri, 64114, United States
-
Alliance for Multispecialty Research, LLC
Knoxville, Tennessee, 37909, United States
-
California Research Foundation
San Diego, California, 92123, United States
-
Guy's and St Thomas' NHS Foundation Trust of St Thomas' Hospital
London, SE1 7EH, United Kingdom
-
Medicine Evaluation Unit Ltd, The Langley Building, Wythenshawe Hospital
Manchester, M239QZ, United Kingdom
-
Royal Surrey County Hospital Foundation Trust, NIHR Royal Surrey Clinical Research Facility
Guildford, GU2 7XP, United Kingdom
-
University Hospital Southampton
Southampton, SO16 6YD, United Kingdom
-
University of Washington Virology Research Clinic
Seattle, Washington, 98104, United States
Conditions
Explore the condition pages connected to this study.